Search

everythinglearnresearchcommunity

for

Search:↓

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Targeted cancer therapies often cause serious skin problems that need careful management.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

New cancer treatments aim to reduce side effects and improve effectiveness.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

A patient with myotonic dystrophy had several autoimmune disorders and thyroid cancer, suggesting a possible link between these conditions.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.